| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/13/1998 | US5707651 Soft capsules containing dinreburnamenine compounds |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/11/1998 | CA2209776A1 New derivatives of 2-(1h)-quinoline, their preparation and pharmaceutical compositions containing them |
| 01/08/1998 | WO1998000425A1 Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine |
| 01/08/1998 | WO1998000412A1 Muscarinic antagonists |
| 01/08/1998 | WO1998000400A1 Tetrahydrobenzindole compounds |
| 01/08/1998 | WO1998000173A2 Targeted drug delivery using sulfonamide derivatives |
| 01/08/1998 | WO1998000142A1 Plaster for the transdermal application of pergolide |
| 01/08/1998 | WO1998000123A1 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders |
| 01/08/1998 | DE19728279A1 Ketoprofen plaster with long-term and immediate effect, |
| 01/08/1998 | DE19626621A1 Pflaster zur transdermalen Anwendung von Pergolid Patch for transdermal administration of pergolide |
| 01/08/1998 | DE19626431A1 Anti-alcoholic and nootropic medicaments |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2259496A1 Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816375A1 Glycoconjugates of opiated substances |
| 01/07/1998 | EP0816356A1 1-(2-(1-piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazole derivatives and their pharmaceutical use |
| 01/07/1998 | EP0815861A1 Sulphonamides and their use |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815227A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815206A1 Cell culture method |
| 01/07/1998 | EP0815134A1 Modulators of amyloid aggregation |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815112A1 Process for isolating galanthamine |
| 01/07/1998 | EP0815107A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 01/07/1998 | EP0815104A1 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 01/07/1998 | EP0815088A1 Aromatic compounds useful as tachykinin antagonists |
| 01/07/1998 | EP0815080A1 Di-substituted 1,4-piperidine esters and amides having 5-ht 4? antagonistic activity |
| 01/07/1998 | EP0814843A2 Hapten-carrier conjugates for use in drug-abuse therapy |
| 01/07/1998 | EP0814842A1 Method for treating amyloidosis |
| 01/07/1998 | EP0814828A1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814812A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 01/07/1998 | EP0814809A1 Aryl thioxanthines |
| 01/07/1998 | EP0814806A1 Use of fused benzothiazoles as neuroprotectants |
| 01/07/1998 | EP0814793A1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814790A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 01/07/1998 | EP0814789A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/07/1998 | EP0814770A1 Process for the preparation of a solid pharmaceutical dosage form |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0672032B1 Novel phenylethyl and phenylpropylamines |
| 01/07/1998 | EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/07/1998 | EP0592490B1 Amino acid derivative anticonvulsant |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | CN1169677A Use of pramipexole as nerveprotective agent |
| 01/07/1998 | CN1169426A Novel pyridajinone derivatives |
| 01/06/1998 | US5705687 Neurotropic drug and method for preparation of same |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705520 Medicaments |
| 01/06/1998 | US5705515 Having reduced side effects |
| 01/06/1998 | US5705511 Fused pyrrolocarbazoles |
| 01/06/1998 | US5705506 Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705401 Method of assaying for alzheimer's disease |
| 01/06/1998 | US5705186 Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | CA2029372C 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049710A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049689A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049287A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997044454A3 Human phospholipase inhibitor |
| 12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CN1168792A Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/31/1997 | CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CA2257964A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/30/1997 | US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders |
| 12/30/1997 | US5703239 Indanylpiperidines as melatonergic agents |
| 12/30/1997 | US5703237 N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands |
| 12/30/1997 | US5703235 N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 12/30/1997 | US5703121 Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound |
| 12/30/1997 | US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger |
| 12/30/1997 | US5703113 Benzopyran derivatives |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703100 Modulators of acetylcholine receptors |
| 12/30/1997 | US5703091 Suitable for the control of diseases |
| 12/30/1997 | US5703087 Phenyl indole compounds |
| 12/30/1997 | US5703083 Therapy for psychological disorders |
| 12/30/1997 | US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703070 Psychological disorders |
| 12/30/1997 | US5703065 Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5703045 Nervous system disorders |
| 12/30/1997 | US5702728 Analgesics; antitumor agents |
| 12/30/1997 | CA2134964C Bridged aza-bicyclic derivatives as substance p antagonists |